Weight Management
Tirzepatide
Dual GIP and GLP-1 receptor agonist for substantial weight loss and metabolic control.
.png&w=3840&q=75)
About Tirzepatide
Tirzepatide is a groundbreaking dual-action receptor agonist targeting both GIP and GLP-1 incretin pathways. By activating both receptors, it synergistically curbs appetite, delays gastric emptying, improves insulin secretion, and recalibrates metabolic health, delivering profound and sustained reductions in body weight.
Key Benefits
Substantial Weight Loss
Promotes profound and sustained reductions in body weight and body fat.
Appetite & Satiety Control
Dramatically reduces cravings and enhances post-meal fullness.
Glycemic Regulation
Optimizes glucose control, insulin sensitivity, and lipid parameters.
Cardiometabolic Health
Supports healthy blood pressure, visceral fat reduction, and cardiovascular markers.
Dosing Guide
Dosage2.5mg (Starting dose)
FrequencyOnce weekly (SubQ)
DurationTitrate up every 4 weeks as tolerated
Helpful Tips
- Administer on the same day each week; can be taken with or without food.
- Prioritize high-protein intake and daily hydration to preserve lean muscle mass.
- Eat smaller, frequent portions to prevent mild early gastrointestinal adjustment symptoms.